Communicable Disease
Communicable Disease
year
» Leading causes of morbidity - communicable • Wild diseases:
diseases a. Water-borne diseases (such as dysentery,
cholera or typhoid fever)
» Communicable diseases – this refers to diseases that
b. Influenza
is brought about by an infectious agent or its toxic
c. Leptospirosis
products that is transmitted directly or indirectly to a
d. Dengue
person, animal or intermediate vector under
conducive environment à reflects the ECOLOGIC
CONTAGIOUS VS. INFECTIOUS [2 Major
TRIAD of DISEASE CAUSATION
Classifications of Communicable Diseases]
» Infectious Agent or its toxic products – AGENT
Contagious
» Diseases that are easily spread directly transmitted
o Pathogenic organism (bacteria, virus, fungi,
from person to person (direct contact) through an
protozoa, or the toxin being produced by the
intermediary host.
pathogenic agent).
Infectious
o Agent – causes/ serves as a stimulus to the
» Diseases that caused by a pathogen not transmitted
development of diseases
by ordinary contact but require a direct inoculation
through a break in the skin or mucous membrane.
» Directly or Indirectly – MODE OF
TRANSMISSION
• Transmitted via indirect contact (through an
inanimate object)
o Person, Animal or Intermediate Vector – HOST
• Skin – open wound à portal of entry of
o Most common: human beings/ person pathogenic organism à may cause infection
• The first line of defense of the body against
o Not limited to humans à these pathogenic infectious microorganism is through an
organisms may stay in other biological beings, intact skin à when handling pts. with
such as animals à (diseases acquired through communicable diseases, one way to protect
animals source/host of pathogenic organism) – oneself is through the use of gloves (serve as
though not all diseases can be acquired through initial barrier against pathogenic organism)
animal-to-human/person transmission. Note: all communicable diseases are infectious but most and not
all are contagious
o Most often, these are acquired through other human
beings in different modes (can be direct or
indirect contact to human beings) CHAIN OF INFECTION
AGENT
» Environment – ENVIRONMENT
Bacteria, Virus, Fungi,
o Milieu which provides opportunity for this Protozoa, Toxins
pathogenic organism to transfer to human being Susceptible Host Reservoir
to produce and cause a disease condition.
Age, Nutritional Status, Level of Stress, Respiratory Tract, GI Tract, Urinary
Underlying Disease, Medical Treatment Tract, Reproductive Tract, Blood
o Example, certain diseases common during the hot/
summer season of the year
• Chicken pox Portal of Entry Portal of exit
• Measles
Nose/Mouth, Urethral Meatus, Nose/Mouth, Urethral Meatus,
• Conjunctivitis Vagina, Open wound Vagina, Open wound
Mortal of transmission
3. PORTAL OF EXIT
» Nose/mouth, Urethral meatus, Vagina, Open They can stay in the air environment
à these microorganisms may enter
Wound through respiratory route causing
infection.
» Respiratory tract à portal of exit: nose/ mouth
à diagnose through sputum microscopy/
5. PORTAL OF ENRTRY
culture of secretions
» Nose/ Mouth, Urethral meatus, Vagina, Open
wound.
» GI tract à anus à Fecalysis
6. SUSCEPTIBLE HOST
4. MODE OF TRANSMISSION
» Susceptibility of the host
» Refers to how this pathogenic organism can
enter through a susceptible host. There are
a) Age
several ways:
o Those who are severely young
(underdeveloped immune system) or severely
old (degenerative changes in older adults /
Senior citizens).
o One of the indications for immunization is o Able to fight the disease à convalescent
malnutrition – highly at risk for acquiring
diseases. o Not able to fight the disease à complications
& death
c) Level of stress
INFECTIOUS AGENT
d) Underlying disease
FACTORS THAT AFFECT THE AGENT TO
o Presence of comorbidity or an underlying DEVELOP A DISEASE
disease condition
1) Pathogenicity
e) Medical Treatment » The ability of the microorganism to cause an
o E.g., if they are undergoing Tx/ receiving infection.
chemotherapy – chemotherapeutic agents
attack not only the abnormal cells but as well o Bacteria and viruses are highly pathogenic by
as the normal cells nature – high chance of causing a disease.
4) Convalescent
» Symptoms abate and return to normal
» Tuberculosis, Measles, Chicken Pox, Small Pox, o Interpretation of control measures to IFC for
SARS practice to prevent spread of CD.
b) Secondary – early diagnosis and » CDs require immediate reporting to the District
treatment Health Offices | Health Center District Health
»
E.g., smallpox – eradicated, 1978, but if Public Hospital
1 – 10,000 à Nurse à 90% Ward
there’s a sudden occurrence after a long period à 10 % Private
1 – 20,000 à Doctor
of time à secular variation - change in the
1 – 5,000 à midwife
frequency of the disease over a long period of Private Hospital
time. à 10 % Ward
à 90 % Private
TYPES OF EPIDEMIOLOGY
III. ISOLATION AND QUARANTINE
1. Descriptive Epidemiology
» Study/ Describe the patterns of diseases 1. Isolation
» Separate the “infected” individual.
2. Analytic Epidemiology o How long?
» Study the factors which causes the development à depend on communicability period of the
or distribution of the disease. disease
à depend on the prodromal stage of the
3. Therapeutic/ Clinical disease
» Study the effectiveness of a treatment/ intervention
» Confirmed disease – isolation
» The use of tawa-tawa grass (Euphorbia hirta) in
the treatment of dengue fever, particularly in rural » Basis of the isolation period convalescent stage
areas when the patient is no longer manifesting the signs
and symptoms
» Study the effectiveness of the different vaccines
against COVID-19 infection 2. Quarantine “FIRST STEP”
» Limit the movement of “suspected” individual.
4. Evaluation Epidemiology o In order to observe for developing signs and
» Evaluate or study the effectiveness of a particular symptoms
health program. o How long?
à depend on the incubation period the days
» E.g., the DOTS (Directly Observed Treatment of quarantine.
Short-Course Chemotherapy) program of the » Suspect
government to fight against TB | effectiveness of
the COVID-19 control program » Basis of the quarantine period is the incubation
period of the disease.
Conducting Epidemiology o Expose to the person who are infected.
Evaluation:
(What, When, Where, Who) 3. FACTORS AFFETING ISOLATION (Source:
Fundamentals of Nursing, Erb and Kozier)
1. Establish fact of presence of epidemic
2. Establish time and space relationship
1) Mode of Transmission
3. Relations to characteristics
4. Correlation of all data obtained. 2) Source
3) Status of the Client’s Defense Mechanism [The
status of the immune system]
TYEPS OF EPIDEMIOLOGIC DATA 4) Ability of Client to Implement Precautions
1. Demographic
2. Vital Statistics
3. Environmental Data
o Source of water
o Source of Food
o Types of households
1. Medical Asepsis/Clean
» Technique
o REDUCE the number and transfer of
pathogens
2. Surgical Asepsis/Sterile
» Technique
o FREE of microorganisms
àBoiling
§ Form of heat sterilization at the
community setting
BCG (Bacillus
At birth 0.05 ml
Calmette – Guerin)
TYPES OF VACCINE
OPV (live
Most Sensitive to attenuated)
- 15 OC to – 25 OC
Heat AMV (Freeze
dried) MMR
DT (weakened
toxin)
P (Toxin)
Hepa B
Least Sensitive to 2OC to – 8 OC
heat REFIGERATOR
BCG
» Discard
• BCG- 4-6 hours
• AMV 6-8 hours
• Others by the end of the day
4. Symptoms of respiratory distress (fast breathing, § For adult: (once every 5 years.)
chest indrawing/retractions, stridor or noisy à PCV- 3 doses IM
inspiration) à 0.5 ml
2. ETHAMBUTOL
§ SE: Optic Neuritis
o Not given to children as it causes blurring of
vision
3. Rifampicin
§ SE: Orange to red output
o Advise the patient to increase fluid intake
4. Streptomycin
MAINTENANCE OF TB PATIENT § SE: 8th CN damage – Tinnitus
o Route: Parenteral, via IM
DRUG FDC – A FDC – B
COMPOSITION 4 – Drug (RHZE) 2 – Drug (RH) 5. Pyrazinamide
RIFAMPICIN ® 150mg 150mg § SE: Joint pains and occasional attacks of gout
INH (H) 75 mg 75mg
Note:
PZA (Z) 400 mg * ALL these ANTI- TB DRUGS ARE HEPATOTOXIC
ETHAMBUTOL * Prior to administration of anti-tb drugs, they should
275mg
(E) undergo liver function test.
= 1Tablet = 1 Tablet
Note: Total
Regimen Type of Pt. Intensive Maintenance
» FDA A- are taken by the patient during the (months)
INTENSIVE PHASE Pyrazinamide, Kanamycin,
Standard Rifampicin
Levofloxacin,
» FDC B- are taken by the patient during Drug Resistant of
Prothionamide, Cyloserine 18 at least
Resistance Multi Drug
MAINTENANCE PHASE (SRDR) Resistant
(Based on Drug Sensitivity
Test Result)
» Taken in MORNING BEFORE MEALS- to ensure
absorption.
» The greater the weight the greater of tablet
à Isoniazid
2 months
à rifampicin
à Pyrazinamide
MAINTENANCE
à isoniazid 4 moths
à Rifampicin
DRUGS DURATION
INTENSIVE
*** Encourage to comply with the Treatment
Regimen*** à Isoniazid
à rifampicin 2 months
à Pyrazinamide
à Strptomycin
Dx of Children with TB
MAINTENANCE
2. Health Education
NURSING CARE: